Journal of Biosciences

, Volume 22, Issue 2, pp 177–192 | Cite as

Conformation of nifedipine in hydrated 1,2-di-myristoyl-sn-glycero-3-phosphorylcholine bilayer molecular dynamics simulation

  • D. Gupta
  • V. Kothekar


The conformation of nifedipine, a cardiac and smooth muscle calcium ion channel antagonist is studied in a hydrated bilayer of forty nine 1,2-di-myristoyl-sn-glycero-3-phosphorylcho-line (DMPC) molecules using molecular dynamics (MD) simulation technique. The simulation was carried out in conditions of constant number, volume and temperature (NVT) at 310 K, which is above the liquid crystalline (Lα) transition temperature of DMPC. The periodic boundary conditions were applied in three-dimensions. Thus the model represented an infinite bilayer. The important geometric parameters characteristic to DMPC and nifedipine molecules were calculated and compared with other theoretical and experimental results pertaining to nifedipine and other related dihydrophyridine (DHP) analogues. Our results suggest that conformational parameters required for antagonist activity are fairly conserved during the interaction of nifedipine with DMPC bilary and bilayer stabilizes the drug conformation in the bioactive form.


Nifedipine DMPC computer simulation molecular dynamics 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Alper H E, Bassolino D and Stouch T R 1993 a Computer simulation of a phospholipids monolayer—water system — The influence of long range forces on water structure and dynamics;j. Chme. Phys. 98 9797–9807Google Scholar
  2. Alper H E, Bassolino D and Stouch T R 1993b The limiting behavior of water hydrating a phospholipid monolayer—A computer simulation study;J. Chem. Phys. 99 5547–5559CrossRefGoogle Scholar
  3. Alper H E and Stouch T R 1995 Orientation and diffusion of a drug analog in biomembranes molecular dynamics simulation;J. Phys. Chem. 99 5724–5731CrossRefGoogle Scholar
  4. Bassolino-Klimas D, Alper H E and Stouch T R 1993 Solute difusion in lipid bilayer membranes: an atomic level study by molecular dynamics simulation;Biochemistry 32 12624–12637PubMedCrossRefGoogle Scholar
  5. Bauerle H D and Seelig J 1991 Interaction of charged and uncharged calcium channel antagonists with phospholipid membrane. Binding equilibrium, binding enthalpy and membrane location;Biochemistry 30 7203–7211PubMedCrossRefGoogle Scholar
  6. Damodaran K V, Merz B M and Gaber B P 1992 Structure and dynamics of the dilauroylphosphatidylethanolamine lipid bilayer;Biochemistry 31 7656–7664PubMedCrossRefGoogle Scholar
  7. Damodaran K V and Merz K M 1993 Head group water interactions in lipid bilayers—a comparison between DMPC based and DLPE based lipid bilayers;Langmuir 9 1179–1183CrossRefGoogle Scholar
  8. Damodaran K V and Merz M K 1994 A comparison of DMPC and DLPE based liquid bilayers;Biophys. J. 66 1076–1083PubMedGoogle Scholar
  9. De Young L R and Dill K A 1988 Solute partitioning into lipid bilayer membranes;Biochemistry 27 5281–5289PubMedCrossRefGoogle Scholar
  10. Edholm O and Johansson J 1987 Lipid bilayer polypeptide interactions studied by molecular dynamics simulation;Eur. Biophys. J. 14 203–209PubMedCrossRefGoogle Scholar
  11. Edholm O and Nyberg A M 1992 Cholesterol in model membranes: a molecular dynamics simulation;Biophys. J. 63 1081–1089PubMedGoogle Scholar
  12. Edholm O, Berendson H J C and Van der Ploeg P 1983 Conformational entropy of a bilayer membrane derived from a molecular dynamics simulation;Mol. Phys. 48, 379–388CrossRefGoogle Scholar
  13. Egberts E 1988Molecular dynamics simulation of multilayer membranes, Ph.D, thesis, University of Groningen, The NetherlandsGoogle Scholar
  14. Egberts E and Berendsen H J C 1988 Molecular dynamics simulation of a smectic liquid crystal with atomic detail;J. Chem. Phys. 89 3718–3732CrossRefGoogle Scholar
  15. Essex J W, Hann M M and Richard W G 1994 Molecular dynamics simulation of a hydrated phospholipid bilayer;Philos. Trans. R. Soc. London B344 239–260Google Scholar
  16. Fossheim R, Svarteng K, Mostad A, Romming C, Shefter E and Triggle D J 1982 Crystal structure and pharmacological activity of calcium channel anatgonists: 2, 6-Dimethyl-3, 5-dicarbomethoxy-4-(unsubstituted, 3-methly, 4-methyl-, 3-nitro-, 4-nitro-, and 2, 4-dinitrophenyl)-l, 4-dihydropyridine;J Med. Chem. 25 126–131PubMedCrossRefGoogle Scholar
  17. Gaudio A C, Korolkovas A and Takahata Y 1994 Channel antagonist (nifedipine analogues): A quantum chemical/classical approach;J. Pharmacol. Sci. 83 1110–1115CrossRefGoogle Scholar
  18. Heller H, Schaefer K and Schulten K 1993 Molecular dynamics simulation of a bilayer of 200 lipids in the gel and liquid crystal phases;J Phys. Chem. 97 8343–8360CrossRefGoogle Scholar
  19. Herbette L G, Van Erve Y M and Phode D G 1989 Interaction of 1, 4-dihydropyridine calcium channel antagonists with biological membranes: lipid bilayer partitioning could occur before drug binding to receptors;J. Mol. Cell Cardiol. 21 187–201PubMedCrossRefGoogle Scholar
  20. Huang P and Loew G H 1995 Interaction of a amphiphilic peptide with a phospholipid bilayer surface by molecular dynamics simulation study;J. Biomol. Struct. Dyn. 12 937–955PubMedGoogle Scholar
  21. Huang P, Bertaccini Ed and Loew G H 1995 Molecular dynamics simulation of anesthetic phospholipid bilayer interactions;J. Biomol. Struct. Dyn. 12 725–754PubMedGoogle Scholar
  22. Janiak M J, Small D M and Shipley G G 1979 Temperature and compositional dependence of the structure of hydrated dimyristoyl lecithin;J Biol. Chem. 254 6068–6078PubMedGoogle Scholar
  23. Janis R A and Triggle D J 1983 New Developments in Ca2 + channel antagonists;J Med. Chem. 26 775–785PubMedCrossRefGoogle Scholar
  24. Janis R A, Silver P and Triggle D J 1987 Drug action and cellular calcium regulation;Adv. Drug. Res. 16 1049–1058Google Scholar
  25. Jorgenson W L, Chandrasekhar J, Medura J D, Impey R W and Klein M M L 1983 Comparison of simple potential functions for simulating liquid water;J Chem. Phys. 79 926–935CrossRefGoogle Scholar
  26. Kaul P and Kothekar V 1988 Dynamic fluoroscence polarization studies on lipid mobilities in phospholipid vescicles in the presence of calcium channel;J Biosci. 13 359–365CrossRefGoogle Scholar
  27. Kothekar V and Gupta D 1994 200 Picosecond molecular dynamics simulation of interaction of nifedipine with 1–2 dimyristoyl phosphatidylcholine membrane;Indian J. Biochem. Biophys. 31 24–30PubMedGoogle Scholar
  28. Kothekar V 1996 Molecular dynamics study of interaction of dimyristoylphosphotidylcholine with water;J Biosci. 21 577–597CrossRefGoogle Scholar
  29. Lang D A and Triggle D J 1985 Conformational features of Calcium channel agonists and antagonists analogs of nifedipine;Mol, Pharmacol. 27 544–548Google Scholar
  30. Levitt M 1983 Molecular dynamics of native proteins. I. Computer simulation of trajectories;J Mol. Biol. 168 595–620PubMedCrossRefGoogle Scholar
  31. Lewis B A and Engleman D M 1983 Lipid bilayer thickness varies linearly with acyl chain length in fluid phosphotidyl choline vescicles;J. Mol. Biol. 166 211–217PubMedCrossRefGoogle Scholar
  32. Mahmoudian M and Richards W G 1986 A conformational distinction between dihydropyridine calcium channel agonists and antagonists;J. Chem. Soc. Chem. Commun. 739–741Google Scholar
  33. Mason R P, Campbell S, Wang S and Herbette L G 1989a Comparison of location and binding for the positively charged 1, 4 dihydropyridine calcium channel antagonist amlodipine with uncharged drugs of this class in cardiac membranes;J. Mol. Pharmacol. 36, 634–640Google Scholar
  34. Mason R P and Chester D W 1989 Diffusional dynamics of an active rhodamine labelled 1, 4 dihydropyridine in sarcolemmal lipid multibilayer;Biophys. J. 56 1193–1201PubMedGoogle Scholar
  35. Mason R P, Gonye G E, Chester D W and Herbette L G 1989b Partitioning and location of Bay K8644, 1,4-dihyd-ropyridine calcium channel channel antagonist, in model and biological membranes;Biophys. J.55 769–778PubMedGoogle Scholar
  36. Mason R P, Rhodes D G and Herbette LG 1991 Reevaluating equilibrium and knetic binding parameters for lipophilic drugs based on a structural model for drug interaction with biological membranes;J. Med. Chem. 34 869–877PubMedCrossRefGoogle Scholar
  37. Mason R P, Moring J and Herbette L G 1990 A molecular model involving the membrane bilayer in the binding of lipid soluble drugs to their receptors in heart and brain;Int. J. Rad. Appl. Instrum. B17 13–33Google Scholar
  38. Mrigank, Royyuru A K and Kothekar V 1986 Origin of sequence specific recognition of DNA by non intercalating anti-tumor antibiotics;FEBS Lett. 195 203–207PubMedCrossRefGoogle Scholar
  39. Pearlman D A, Case D A, Caldwell J C, Singh U C, Weiner P K and Kollman P A 1991 University of California, AMBER 4.0: Assisted Model Building with Energy Refinement: A Computer Simulation softwareGoogle Scholar
  40. Pearson R H and Pascher 11979 The molecular structure of lecithin dihydrate;Nature (London)281 499–501Google Scholar
  41. Pople J A, Santry D P and Segal G A 1965 Approximate self consistent molecular orbital theory I. Invarient procedures;J. Chem. Phys. 43 129–135CrossRefGoogle Scholar
  42. Rhodes D G, Sarmiento J G and Herbette L G 1985 Kinetics of binding of membrane active drugs to receptor sites. Diffusion linked rates for a membrane bilayer approach of 1,4 dihydropyridine calcium channel antagonists to their active site;Mol. Pharmacol. 27 612–623PubMedGoogle Scholar
  43. Robinson A J, Richards W G, Thomas P J and Hann M M 1995 Behavior of cholesterol and its effect on head group and chain conformations in lipid bilayers-a molecular dynamics study;Biophys. J. 68 164–170PubMedCrossRefGoogle Scholar
  44. Rovnyak G C, Kimball S D, Beyer B, Cucinotta G, Di Marco J D, Gougoutas J, Hedberg A, Malley M, McCarthy J P, Zhang R and Moreland S 1995 Calcium entry blockers and activators: conformational and structural determinants of dihydropyridine calcium channel modulators;J. Med. Chem. 38 119–129PubMedCrossRefGoogle Scholar
  45. Stouch T R 1993 Lipid membrane structure and dynamics studied by all atom molecular dynamics simulations ofhydratedphospholipid bilayers;Mol Simul. 10 317–345CrossRefGoogle Scholar
  46. Stouch T R, Ward K B, Altieri A and Hagler A T 1991 Simulation of liquid crystals: characterisation of potential energy functions and parameters for lecithin molecules;J. Comput. Chem. 12 1033–1046CrossRefGoogle Scholar
  47. Sundaralingam M 1972 Discussion paper: molecular structure and conformations of the phospholipids and sphingomyelins;Ann. N. O Acad. Sci. USA 195 324–355CrossRefGoogle Scholar
  48. Tiku P and Kothekar V 1988 Theoretical study on specificity and Molecular mechanism of action of calcium ion mediators;Curr. Sci. 57 1049–1058Google Scholar
  49. Triggle D J, Hawthorn M, Gopalkrishnan M, Minarini A, Avery S, Rutefedge A, Baugaleri R and Zheng W C 1991 Synthetic organics ligands active at voltage gated calcium channel;Ann. N. Y.Acad. Sci. USA 635 123–138CrossRefGoogle Scholar
  50. van der Ploeg P and Berendsen H J C 1982 Molecular dynamics of a bilayer membrane;J. Chem. Phys. 76 3271–3276CrossRefGoogle Scholar
  51. van der Ploeg P and Berendsen H J C 1983 Molecular dynamics of a bilayer membrane;Mol. Phys. 49 233–248CrossRefGoogle Scholar
  52. Venable R M, Zang Y, Hardy B J and Pastor R W 1993 Molecular dynamics simulations of a lipid bilayer and of hexadecane—an investigation of membrane fluidity;Science 262 223–226PubMedCrossRefGoogle Scholar
  53. Weiner S J, Kollman P A, Case D A, Singh U C, Ghio C, Alagona G, Profeta S and Weiner P 1984 A new forcefield for molecular mechanical simulation of nucleic acids;Am. Chem. Soc. 106 7650–784CrossRefGoogle Scholar

Copyright information

© Indian Academy of Sciences 1997

Authors and Affiliations

  1. 1.Department of BiophysicsAll India Institute of Medical SciencesNew DelhiIndia

Personalised recommendations